BioCentury
ARTICLE | Distillery Techniques

Techniques: Prostate-specific membrane antigen (PSMA; FOLH1; GCPII)-targeting PET imaging agent to detect prostate cancer

June 16, 2016 7:00 AM UTC

Phosphoramidate-based PSMA-targeting PET imaging agents could help detect prostate cancer. The two agents consisted of 18F-labeled aminohexanoic acid-phosphoramidate analogs that irreversibly bound PS...